Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus (Q44910555)

7 December 2017

title

Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus (English)

1 reference

Infectious bursal disease virus

7 December 2017

main subject

object named as

infectious bursal disease virus

1 reference

Yong-shan Wang

1

1 reference

7 December 2017

Hong-jie Fan

2

1 reference

7 December 2017

Yin Li

3

1 reference

7 December 2017

Zheng-liang Shi

4

1 reference

7 December 2017

Ying Pan

5

1 reference

7 December 2017

Cheng-ping Lu

6

1 reference

7 December 2017

language of work or name

English

0 references

publication date

26 March 2007

1 reference

7 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

7 December 2017

volume

25

1 reference

7 December 2017

issue

22

1 reference

7 December 2017

page(s)

4447-4455

1 reference

Research on infectious bursal disease--the past, the present and the future

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Identification of a novel viral protein in infectious bursal disease virus-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Genomic structure of the large RNA segment of infectious bursal disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Sequence Analysis and Expression of the Host-protective Immunogen VP2 of a Variant Strain of Infectious Bursal Disease Virus Which Can Circumvent Vaccination with Standard Type I Strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Mapping of conformational epitopes on capsid protein VP2 of infectious bursal disease virus by fd-tet phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Identification of crucial residues of conformational epitopes on VP2 protein of infectious bursal disease virus by phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Expression in Escherichia coli of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Expression and characterization of infectious bursal disease virus polyprotein in yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Expression of ORF A1 of infectious bursal disease virus results in the formation of virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Protection from IBDV-induced bursal damage by a recombinant fowlpox vaccine, fpIBD1, is dependent on the titre of challenge virus and chicken genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Active cross-protection induced by a recombinant baculovirus expressing chimeric infectious bursal disease virus structural proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

More bumps on the vaccine road.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Current and future recombinant viral vaccines for poultry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Use of T7 RNA polymerase to direct expression of cloned genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Vaccine technologies: view to the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Rational dissection of binding surfaces for mimicking of discontinuous antigenic sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Replication of infectious bursal disease virus in continuous cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

Characteristics and Serologic Studies of Two Serotypes of Infectious Bursal Disease Virus in Turkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

VP5 of infectious bursal disease virus is not essential for viral replication in cell culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.03.018

1 reference

7 December 2017

1 reference